secwatch.observer — SEC 8-K summary
======================================

Issuer:     PDS Biotechnology Corp (PDSB)
CIK:        0001472091
Form:       8-K
Filed at:   2026-09-14T20:10:46+00:00
Accession:  0001140361-26-036489
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 1.02, 5.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PDS Biotech completes $11.3M PIPE led by Nant; adds Soon-Shiong and Banaag to board
--------------------------------------------------------------------------------

- Initial closing: issued 16,502,870 shares, 23,498,156 pre-funded warrants, 20,000,514 common warrants; gross $11.3M.
- Nant (Soon-Shiong) bought $10M of securities; Milestone Closing obligates Nant ($10M) and AB Group ($1M) to buy more.
- Dr. Patrick Soon-Shiong (Class C) and James Banaag (Class A) appointed to board effective Sept 14, 2026.
- Redeemed $6M Yorkville promissory note for ~$4.6M in full; no early termination penalties.
- Proceeds to repay debt, working capital, and advance PDS0301 into late-stage development.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472091/000114036126036489/0001140361-26-036489-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472091/000114036126036489/ef20081956_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-036489

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer